Moderna sues Pfizer and BioNTech, alleging copying of mRNA tech
Moderna said the companies ‘failed’ to respect its intellectual property rights over its COVID-19 vaccine.
Stay updated with breaking news from Thyme Klinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna said the companies ‘failed’ to respect its intellectual property rights over its COVID-19 vaccine.
Moderna sues Pfizer, BioNTech, alleging they copied patented mRNA technology. From PR Week
Moderna Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Updates Read full article Oops! SARS-CoV-2 Variant Booster Program Update : Single booster dose of 50 µg of mRNA-1273 or mRNA-1273.351 increased neutralizing titers against SARS-CoV-2 and two Variants of Concern (B.1.351, P.1) in previously vaccinated clinical trial participants TeenCOVE Study Update : Initial analysis of the Phase 2/3 TeenCOVE study of mRNA-1273 showed vaccine efficacy against COVID-19 of 96%; mRNA-1273 was generally well tolerated with no serious safety concerns identified to date 2021 a...